: £12.9 million (+27.4%), supported by synthetic biology.
"5414X" is the RNS (Regulatory News Service) identifier for the released by Oxford Nanopore Technologies plc . : £12
: A refined commercial strategy identified high-priority opportunities in applied and research markets worth an estimated $13 to $14 billion . : £12.9 million (+27.4%)